Grant of share-based long-term incentive instruments to members of the Board of Management and key employees

Link
https://www.globenewswire.com/news-release/2025/04/03/3055331/0/en/Grant-of-sha…
Created date
Nasdaq ID
3055331
Last updated: 2025.04.03

Veeva System Specialist

EasyCruit ID
3484393
Department ID
5378
Location
Hørsholm, Denmark
Vacancy URL
https://alkabello.easycruit.com/vacancy/3484393/5378
Expire Date
Last updated: 2025.05.14

Annual report 2024: ALK delivers 15% sales growth with profits up 65%

Link
https://www.globenewswire.com/news-release/2025/02/19/3028468/0/en/Annual-repor…
Created date
Nasdaq ID
3028468
Last updated: 2025.03.24

Annual General Meeting in ALK-Abelló A/S on 13 March 2025

Link
https://www.globenewswire.com/news-release/2025/02/19/3028793/0/en/Annual-Gener…
Created date
Nasdaq ID
3028793
Last updated: 2025.03.24

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff

Link
https://www.globenewswire.com/news-release/2025/02/21/3030519/0/en/Report-on-tr…
Created date
Nasdaq ID
3030519
Last updated: 2025.03.24

Annual General Meeting in ALK-Abelló A/S held on 13 March 2025

Link
https://www.globenewswire.com/news-release/2025/03/13/3042490/0/en/Annual-Gener…
Created date
Nasdaq ID
3042490
Last updated: 2025.03.13

Senior Manager Pharmacovigilance (m/w/d)

EasyCruit ID
3451493
Department ID
112661
Location
Hamburg
Vacancy URL
https://alkabello.easycruit.com/vacancy/3451493/112661
Expire Date
Last updated: 2025.03.10

ACARIZAX® approved in Canada for treatment of young children

Link
https://www.globenewswire.com/news-release/2025/03/07/3038942/0/en/ACARIZAX-app…
Created date
Nasdaq ID
3038942
Last updated: 2025.03.07

Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff

Link
https://www.globenewswire.com/news-release/2025/03/04/3036986/0/en/Report-on-tr…
Created date
Nasdaq ID
3036986
Last updated: 2025.03.04

FDA approves ODACTRA® for the treatment of house dust mite allergy in young children

Link
https://www.globenewswire.com/news-release/2025/02/27/3034245/0/en/FDA-approves…
Created date
Nasdaq ID
3034245
Last updated: 2025.02.27
Subscribe to